Sight Diagnostics received a CE mark for its point-of-care blood diagnostic device, OLO.

Sight Diagnostics received a CE mark for its point-of-care blood diagnostic device, OLO, which uses artificial intelligence to optically read small amounts of blood and provide complete blood count tests during a single doctor’s visit.

After taking two drops of blood from a finger prick or venous draw, a physician can place them into a self-contained, disposable cartridge, which is then fed into the tabletop machine. Test results are then displayed on a screen within minutes. OLO employs digital, multichannel microscopy—using algorithms to visually analyze different cell types by size, shape, count and morphologyw.

Comment: The idea is for clinicians to use the device to perform the most prevalent medical blood diagnostics test directly in their office, rather than a patient having venous blood drawn and sent away to a lab for analysis -- a process that can take a few days.